Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Retinal Imaging Biomarkers in Early Alzheimer's Disease

NCT01937221 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT01937221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01937221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Retinal Imaging Biomarkers in Early Alzheimer's Disease
Lead sponsor
Duke University
Phase
Observational
Overall status
Completed
Start date
September 30, 2013
Completion date
July 31, 2017
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mild cognitive impairment, mild to moderate cognitive impairment